Last reviewed · How we verify
NCT07342608: STARLIGHT
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NA trial testing Use of LINEA cardiac pacing lead in Bradycardia in 450 participants. Not yet recruiting.
31 January 2027
Quick facts
| Lead sponsor | MicroPort CRM |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 450 |
| Start date | 31 March 2026 |
| Primary completion | 31 January 2027 |
| Estimated completion | 30 April 2030 |
Drugs / interventions tested
- Use of LINEA cardiac pacing lead
Conditions studied
- Bradycardia — all drugs for Bradycardia →
- Left Bundle Branch Area Pacing — all drugs for Left Bundle Branch Area Pacing →
- Left Bundle Branch Pacing — all drugs for Left Bundle Branch Pacing →
Sponsor
MicroPort CRM — full company profile →
Who can join
18 and older, any sex, with Bradycardia or Left Bundle Branch Area Pacing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the clinical investigation is to evaluate the safety and performances of the new LINEA cardiac pacing lead, intended for placement at the interventricular septum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07342608
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bradycardia
Currently open trials in the same condition.
- NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up · recruiting
- NCT07254013 — Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution · NA · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07585799 — Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conductio · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
Other MicroPort CRM trials
Trials by the same sponsor.
- NCT07254013 — Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution · NA · recruiting
- NCT05694572 — Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices · recruiting
- NCT04590144 — Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO) · NA · completed
- NCT04753749 — Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Pati · NA · completed
- NCT04118803 — Observational Study on Inappropriate Therapies · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07342608 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MicroPort CRM
- Last refreshed: 17 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07342608.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing